Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Ear Hear. 2019 Jul-Aug;40(4):1016–1024. doi: 10.1097/AUD.0000000000000684

Table 3:

Subject CI device information

N (%)
CI company Advanced Bionics 43 (11.5%)
Cochlear 216 (58.2%)
MED-EL 112 (30.1%)
Listening Modality Unilateral CI with no contralateral HA 87 (23.4%)
Unilateral CI with hearing aid 96 (25.8%)
Bilateral CI 188 (50.6%)
Combined electro-acoustic hearing (Hybrid) No 358 (96.4%)
Yes 12 (3.2%)
No response 1 (0.2%)